姜黄素通过抑制TXNIP/TRX-1/GPX4通路介导的铁死亡减轻脓毒症小鼠肺损伤

doi:10.12122/j.issn.1673-4254.2024.09.21

摘要/Abstract

摘要：

目的探究姜黄素（Cur）是否通过调控TXNIP/TRX-1/GPX4通路抑制铁死亡减轻脓毒症肺损伤。方法雄性C57BL/6小鼠随机分为Sham组、脓毒症（盲肠结扎穿孔术，CLP）组、CLP+各浓度Cur（50、100和200 mg/kg）组、CLP+Cur（200 mg/kg）+TRX-1抑制剂PX-12（25 mg/kg）组，10只/组，检测各组小鼠肺组织炎症因子及铁死亡关键因子MDA、MPO、GSH水平。Beas-2B细胞分为Con组、脂多糖组（LPS，1 μg/mL）、LPS+各浓度Cur（2.5、5、10 μmol/L）及LPS+Cur （10 μmol/L）+PX-12 （5 μmol/L）组，检测MDA和Fe²⁺水平，DHE染色评估ROS变化。Western blotting检测肺组织和Beas-2B细胞TXNIP、TRX-1、GPX4和X-CT蛋白表达水平。结果与Sham组相比，CLP组小鼠肺损伤严重，IL-6、IL-1β、TNF-α、MDA、MPO含量增加，GSH含量下降（P<0.01）；与CON组相比，LPS组MDA、Fe²⁺、ROS水平升高；CLP组肺组织和LPS组Beas-2B细胞TXNIP蛋白表达增加，TRX-1、GPX4及X-CT蛋白表达减低（P<0.01）；与CLP组相比，CLP+Cur各浓度组肺损伤减轻，炎症因子和脂质过氧化因子含量降低，GSH水平升高；与LPS组相比，LPS+Cur各浓度组Fe^2＋、MDA和ROS水平下降（P<0.05）；TXNIP蛋白表达降低，TRX-1、GPX4及X-CT蛋白表达增加（P<0.01）。PX-12干预后，取消了Cur对脓毒症肺组织和Beas-2B细胞的保护作用（P<0.05）。结论姜黄素通过升高TRX-1、GPX4，降低TXNIP抑制铁死亡，减轻脓毒症肺损伤。

关键词: 脓毒血症肺损伤, 姜黄素, 铁死亡, TXNIP/TRX-1/GPX4通路

Abstract:

Objective To investigate whether curcumin alleviates septic lung injury by inhibiting ferroptosis through modulating the TXNIP/TRX-1/GPX4 pathway. Methods Male C57BL/6 mice were randomly divided into Sham group, cecal ligation puncture (CLP)-induced sepsis group, CLP with curcumin treatment (50, 100, and 200 mg/kg) groups, and CLP with both curcumin (200 mg/kg) and TRX-1 inhibitor PX-12 (25 mg/kg) treatment group. Inflammatory factors, MDA, MPO, and GSH levels in the lung tissue of the mice were detected. Beas-2B cells stimulated with lipopolysaccharide (LPS; 1 μg/mL) were treated with 2.5, 5, or 10 μmol/L curcumin or with 10 μmol/L curcumin combined with 5 μmol/L PX-12, and the changes in MDA, Fe²⁺ and ROS levels were assessed. Western blotting was performed to detect the protein expressions of TXNIP, TRX-1, GPX4 and X-CT in both the mouse lung tissues and Beas-2B cells. Results The mice with CLP-induced sepsis showed severe lung injury with elevated expressions of IL-6, IL-1β, TNF-α, MDA and MPO and decreased GSH expression. In Beas-2B cells, LPS stimulation significantly increased MDA and Fe²⁺ levels and ROS release, increased TXNIP protein expression, and lowered the protein expression levels of TRX-1, GPX4 and X-CT, and these changes were also observed in the septic mice. Curcumin treatments at different concentrations obviously alleviated lung injury in the septic mice and reduced LPS-induced injury in Beas-2B cells. Curcumin significantly decreased the release of inflammatory factors, MDA and MPO, increased GSH level, lowered Fe²⁺, MDA and ROS levels, increased TXNIP protein expression, and lowered the protein expressions of TRX-1, GPX4 and X-CT in both septic mouse lung tissues and LPS-stimulated Beas-2B cells. The protective effect of curcumin was effectively blocked by PX-12 treatment. Conclusion Curcumin inhibits ferroptosis and alleviates septic lung injury in mice by elevating TRX-1 and GPX4 and decreasing TXNIP in the lung tissue.

Key words: sepsis lung injury, curcumin, ferroptosis, TXNIP/TRX-1/GPX4 pathway

陈凯, 孟兆菲, 闵静婷, 王佳慧, 李正红, 高琴, 胡俊锋. 姜黄素通过抑制TXNIP/TRX-1/GPX4通路介导的铁死亡减轻脓毒症小鼠肺损伤[J]. 南方医科大学学报, 2024, 44(9): 1805-1813.

Kai CHEN, Zhaofei MENG, Jingting MIN, Jiahui WANG, Zhenghong LI, Qin GAO, Junfeng HU. Curcumin alleviates septic lung injury in mice by inhibiting TXNIP/TRX-1/GPX4-mediated ferroptosis[J]. Journal of Southern Medical University, 2024, 44(9): 1805-1813.

图/表 10

图1 各组小鼠肺组织HE染色和肺损伤评分

Fig.1 HE staining of lung tissue of the mice and lung injury scores in each group. A: HE staining of paraffin sections of the lung tissues. B: Comparison of lung injury scores among the groups. **P<0.01 vs Sham group; #P<0.05, ##P<0.01 vs CLP group; &&P<0.01 vs CLP+Cur-H group (Mean±SD, n=6).

图2 各组小鼠肺组织IL-1β、IL-6和TNF-α含量表达结果

Fig.2 Expressions of IL-1β (A), IL-6 (B) and TNF-α (C) in the lung tissues of the mice in each group. **P<0.01 vs Sham group; #P< 0.05, ##P<0.01 vs CLP group; &P<0.05, &&P<0.01 vs CLP+Cur-H group (Mean±SD, n=6).

图3 各组小鼠MDA、MPO和GSH水平的结果

Fig.3 Determination of MDA （A）, MPO （B） and GSH （C） levels in the lung tissues of the mice in each group. **P<0.01 vs Sham group; #P<0.05, ##P<0.01 vs CLP group; &&P<0.01 vs CLP+Cur-H group （Mean±SD, n=6）.

图4 各组小鼠Western blotting的结果

Fig.4 Results of Western blotting in each group. A： Western blots of TXNIP, TRX-1, GPX4 and X-CT proteins in the lung tissues of the mice in each group. B-E： Quantitative analysis of the protein levels. **P<0.01 vs Sham group; ##P<0.01 vs CLP group; &&P<0.01 vs CLP+Cur-H group （Mean±SD, n=3）.

图5 CCK8法检测LPS最适造模浓度和时间结果

Fig.5 CCK8 assay for determining the optimal concentration and time of LPS for cell treatment. A： Cell viability assay after LPS treatment at 0, 0.1, 1, 5 and 10 μg/mL for 24 h. B： Cell viability assay after LPS treatment at 0, 0.1, 1, 5 and 10 μg/mL concentrations for 6, 12 and 24 h. *P<0.05, **P<0.01 vs 0 μg/mL group （Mean±SD, n=4）.

图6 姜黄素和PX-12对细胞活力的影响

Fig.6 Effects of curcumin and PX-12 on cell viability. A: Effect of curcumin on cell viability; B: Effect of PX-12 on cell viability. *P<0.05, **P<0.01 vs 0 μg/mL group (Mean±SD, n=4)

图7 各组细胞CCK8活性检测结果

Fig.7 CCK8 assay of cell viability in each group of cells. **P<0.01 vs CON;##P<0.01 vs LPS; &&P<0.01 vs LPS+Cur-H (Mean±SD, n=4).

图8 各组细胞MDA和Fe2+含量表达

Fig.8 Changes in MDA （A） and Fe2+ （B） levels in the cells in each group. **P<0.01 vs control; #P<0.05, ##P<0.01 vs LPS; &&P<0.01 vs LPS+Cur-H （Mean±SD, n=4）.

图9 各组细胞ROS免疫荧光和荧光强度的结果

Fig.9 ROS immunofluorescence and fluorescence intensity in each group of cells. A: Immunofluorescence images of Beas-2B cells in each group. B: Comparison of ROS fluorescence intensity of the cells. **P<0.05 vs control group; ##P<0.01 vs LPS group; &&P<0.01 vs LPS+Cur-H group (Mean±SD, n=4).

图10 各组细胞Western blotting的结果

Fig.10 Western blotting for the proteins in the TXNIP/TRX-1/GPX4 pathways in each group of cells. A: Western blots of the proteins. B-E: Quantitative analysis of the protein expression levels. **P<0.01 vs control group; ##P<0.01 vs LPS group; &&P<0.01 vs LPS+Cur-H group （Mean±SD, n=3）.

参考文献 31

1	Sun BS, Lei MX, Zhang JQ, et al. Acute lung injury caused by sepsis: how does it happen[J]? Front Med, 2023, 10: 1289194.
2	Li WL, Li D, Chen YS, et al. Classic signaling pathways in alveolar injury and repair involved in sepsis-induced ALI/ARDS: new research progress and prospect[J]. Dis Markers, 2022, 2022: 6362344.
3	Wang YF, Zhao ZJ, Xiao ZY. The emerging roles of ferroptosis in pathophysiology and treatment of acute lung injury[J]. J Inflamm Res, 2023, 16: 4073-85.
4	Chen Y, Fang ZM, Yi X, et al. The interaction between ferroptosis and inflammatory signaling pathways[J]. Cell Death Dis, 2023, 14(3): 205.
5	Huo L, Liu CF, Yuan YJ, et al. Pharmacological inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage[J]. Eur J Med Chem, 2023, 257: 115438.
6	Zhang J, Zheng YP, Wang Y, et al. YAP1 alleviates sepsis-induced acute lung injury via inhibiting ferritinophagy-mediated ferroptosis[J]. Front Immunol, 2022, 13: 884362.
7	Zhang XY, Liu CM, Ma YH, et al. The TXNIP/Trx-1/GPX4 pathway promotes ferroptosis in hippocampal neurons after hypoxia-ischemia in neonatal rats[J]. Chin J Contemp Pediatr, 2022, 24(9): 1053-60.
8	Sadeghi M, Dehnavi S, Asadirad A, et al. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases[J]. Inflammopharmacology, 2023, 31(3): 1069-93.
9	Wang Y, Wang YJ, Cai N, et al. Anti-inflammatory effects of curcumin in acute lung injury: in vivo and in vitro experimental model studies[J]. Int Immunopharmacol, 2021, 96: 107600.
10	Yuan R, Li YQ, Han S, et al. Fe-curcumin nanozyme-mediated reactive oxygen species scavenging and anti-inflammation for acute lung injury[J]. ACS Cent Sci, 2022, 8(1): 10-21.
11	Zheng YX, Wang JP, Ling ZY, et al. A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications[J]. J Transl Med, 2023, 21(1): 620.
12	Tao HP, Shen LH. Research progress of curcumin in the treatment of sepsis[J]. Shock, 2024, 61(6): 805-16.
13	Liu RF, Fang XH, Meng C, et al. Lung inflation with hydrogen during the cold ischemia phase decreases lung graft injury in rats[J]. Exp Biol Med, 2015, 240(9): 1214-22.
14	Zhou X, Liao YX. Gut-lung crosstalk in sepsis-induced acute lung injury[J]. Front Microbiol, 2021, 12: 779620.
15	Zhang H, Liu JL, Zhou YL, et al. Neutrophil extracellular traps mediate m⁶A modification and regulates sepsis-associated acute lung injury by activating ferroptosis in alveolar epithelial cells[J]. Int J Biol Sci, 2022, 18(8): 3337-57.
16	Wang W, Xu RL, He P, et al. CircEXOC5 aggravates sepsis-induced acute lung injury by promoting ferroptosis through the IGF₂BP₂/ATF3 axis[J]. J Infect Dis, 2024, 229(2): 522-34.
17	Ahmad S, Zaki A, Manda K, et al. Vitamin-D ameliorates sepsis-induced acute lung injury via augmenting miR-149-5p and downregulating ER stress[J]. J Nutr Biochem, 2022, 110: 109130.
18	Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4):266-82.
19	Shi X, Han B, Zhang B, et al. Schisandra chinensis polysaccharides prevent cardiac hypertrophy by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and inhibiting oxidative stress[J]. Biomed Pharmacother, 2021, 139:111688.
20	Lv HM, Zhu C, Wei W, et al. Enhanced Keap1-Nrf2/Trx-1 axis by daphnetin protects against oxidative stress-driven hepatotoxicity via inhibiting ASK1/JNK and Txnip/NLRP3 inflammasome activation[J]. Phytomedicine, 2020, 71: 153241.
21	Choi EH, Park SJ. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target[J]. Exp Mol Med, 2023, 55(7): 1348-56.
22	Chen YF, Yin HW, Sun J, et al. TrxR/Trx inhibitor butaselen ameliorates pulmonary fibrosis by suppressing NF‑κB/TGF‑β1/Smads signaling[J]. Biomedecine Pharmacother, 2023, 169: 115822.
23	周滟, 李晓茜, 汪思琴. 血清OSM、Trx-1及HBP与脓毒症严重程度相关性及对临床转归的预测研究[J].临床和实验医学杂志, 2024, 23(5): 473-7.
24	Shen K, Wang XJ, Wang YW, et al. MiR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1/Nrf2/GPX4 in sepsis lung injury[J]. Redox Biol, 2023, 62: 102655.
25	Kumar A, Harsha C, Parama D, et al. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases[J]. Phytother Res, 2021, 35(12): 6768-801.
26	Shi Y, Wu Q, Lu Y, et al. Arginine-Glycine-aspartic acid-anchored curcumin-based nanotherapeutics inhibit pyroptosis-induced cytokine release syndrome for in vivo and in vitro sepsis applications[J]. Curr Pharm Des, 2023, 29(4): 283-94.
27	Ahmadabady S, Beheshti F, Shahidpour F, et al. A protective effect of curcumin on cardiovascular oxidative stress indicators in systemic inflammation induced by lipopolysaccharide in rats[J]. Biochem Biophys Rep, 2021, 25: 100908.
28	Zhou Y, Gao LP, Xia P, et al. Glycyrrhetinic acid protects renal tubular cells against oxidative injury via reciprocal regulation of JNK-connexin 43-thioredoxin 1 signaling[J]. Front Pharmacol, 2021, 12: 619567.
29	Li WC, Xu XT, Dong DD, et al. Up-regulation of thioredoxin system by puerarin inhibits lipid uptake in macrophages[J]. Free Radic Biol Med, 2021, 162: 542-54.
30	林全德, 闫艳, 刘晴, 等. PX-12促进硼替佐米诱导多发性骨髓瘤细胞H929凋亡的实验研究[J]. 中国实验血液学杂志, 2021, 29(2): 515-9.
31	Lin Y, Chen XW, Yu CC, et al. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy[J]. Acta Biomater, 2023, 159: 300-11.

[1]	陈鑫源, 吴成挺, 李瑞迪, 潘雪芹, 张耀丹, 陶俊宇, 林才志. 双术汤通过P53/SLC7A11/GPX4通路诱导胃癌细胞铁死亡[J]. 南方医科大学学报, 2025, 45(7): 1363-1371.
[2]	张梦影, 赵晨玲, 田丽伟, 余郭芳, 杨文明, 董婷. 肝豆扶木汤通过GPX4/ACSL4/ALOX15通路抑制铁死亡改善Wilson病小鼠的肝脏脂肪变性[J]. 南方医科大学学报, 2025, 45(7): 1471-1478.
[3]	李丹丹, 楚佳鑫, 闫妍, 徐文隽, 朱行春, 孙韵, 丁浩峰, 任丽, 朱博. 姜黄素通过下调HIF-1α通路抑制非小细胞肺癌脂质代谢[J]. 南方医科大学学报, 2025, 45(5): 1039-1046.
[4]	张安邦, 孙秀颀, 庞博, 吴远华, 时靖宇, 张宁, 叶涛. 电针预处理通过调节肠道-大脑轴及Nrf2/HO-1信号通路抑制铁死亡减轻大鼠脑缺血再灌注损伤[J]. 南方医科大学学报, 2025, 45(5): 911-920.
[5]	张林落, 李长青, 皇玲玲, 周学平, 娄媛媛. 梓醇扶正制毒配伍从SLC7A11/GPX4通路抑制铁死亡减轻雷公藤甲素肝毒性[J]. 南方医科大学学报, 2025, 45(4): 810-818.
[6]	季春斐, 左宗超, 王钧, 李妙男. N-乙酰神经氨酸中通过抑制Nrf2轴促进缺氧/复氧损伤的H9C2心肌细胞发生铁死亡[J]. 南方医科大学学报, 2025, 45(1): 72-79.
[7]	欧阳明子, 崔佳琦, 王慧, 梁正, 皮大锦, 陈利国, 陈前军, 吴迎朝. 开心散通过减轻前额叶皮质铁死亡缓解小鼠的阿霉素化疗性抑郁[J]. 南方医科大学学报, 2024, 44(8): 1441-1449.
[8]	张银亮, 骆泽谭, 赵睿, 赵娜, 徐志东, 奥迪, 丛古一, 刘新宇, 郑海伦. 血根碱通过调控STUB1/GPX4诱导直肠癌细胞发生铁死亡[J]. 南方医科大学学报, 2024, 44(8): 1537-1544.
[9]	王元国, 张鹏. 铁死亡抑制基因在食管癌中的高表达分析[J]. 南方医科大学学报, 2024, 44(7): 1389-1396.
[10]	何华星, 刘璐琳, 刘颖茵, 陈纳川, 孙素霞. 丁酸钠与索拉非尼可能通过YAP诱导铁死亡协同抑制肝癌细胞增殖[J]. 南方医科大学学报, 2024, 44(7): 1425-1430.
[11]	任智先, 周倍贤, 王林鑫, 李菁, 张荣平, 潘锡平. 5-羟基-6，7-二甲氧基黄酮抑制流感病毒诱导A549细胞炎症反应和铁死亡的作用及机制[J]. 南方医科大学学报, 2024, 44(6): 1070-1078.
[12]	张方圆, 刘刚. 右美托咪定通过激活Nrf2/HO-1/GPX4通路抑制肾小管上皮细胞的铁死亡[J]. 南方医科大学学报, 2024, 44(6): 1135-1140.
[13]	王南, 石斌, 马小兰, 吴伟超, 曹佳. FMRP通过激活RAS/MAPK信号通路抑制结直肠肿瘤细胞的铁死亡[J]. 南方医科大学学报, 2024, 44(5): 885-893.
[14]	李淑贤, 于淑平, 穆亚铭, 王凯, 刘玉, 张美华. 二甲双胍通过抑制铁死亡改善PM2.5导致的胎盘滋养细胞功能损伤[J]. 南方医科大学学报, 2024, 44(3): 437-446.
[15]	张榆雪, 蓝洁莹, 马昕怡, 周琼, 秦梦晨, 高磊. 化橘红配方颗粒通过维持铁稳态并抑制脂质过氧化和铁死亡缓解斑马鱼脂肪性肝病[J]. 南方医科大学学报, 2024, 44(12): 2265-2275.